Stratedigm, Inc.

Stratedigm, Inc. is a biotechnology company based in San Jose, California, that specializes in the design and manufacture of flow cytometry instrumentation and software. Founded in 2004, the company focuses on creating compact, modular, and configurable benchtop systems, such as its flagship S1000 series, which are engineered for high-throughput automation and performance. Stratedigm distinguishes its platform by integrating modular hardware components with intuitive software, allowing labs to expand their capabilities and perform complex analysis without the need to replace entire systems. Their approach emphasizes technological longevity, reflected in programs like their Anti-Obsolescence Guarantee and the Flowraissance upgrade path, which allow customers to field-upgrade older instruments to the latest hardware and software specifications. By prioritizing modularity, Stratedigm enables laboratories to adapt to evolving research needs while maintaining consistent workflows and reducing long-term capital expenditure. The company serves a diverse range of research customers, providing solutions that combine analytical sensitivity with industrial-grade reliability and automated workflows. Its dedication to the product lifecycle and customer support is a core component of its value proposition, aimed at solving the industry-wide challenges of instrument bulk, rising costs, and premature obsolescence. Through these initiatives, Stratedigm supports labs in maintaining productive, state-of-the-art cytometry operations that are scalable and resilient to changing technological standards.